Investment analysts at StockNews.com started coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Free Report) in a report released on Wednesday. The brokerage set a “sell” rating on the stock.
Ayala Pharmaceuticals Stock Performance
Shares of ADXS opened at $0.02 on Wednesday. The company has a 50-day simple moving average of $0.16 and a 200-day simple moving average of $0.45. Ayala Pharmaceuticals has a 52 week low of $0.00 and a 52 week high of $1.49. The firm has a market capitalization of $852,660.00, a P/E ratio of 0.00 and a beta of 1.56.
About Ayala Pharmaceuticals
See Also
- Five stocks we like better than Ayala Pharmaceuticals
- How to Use the MarketBeat Stock Screener
- Buy On Holdings Stock Before the Market Catches Its Second Wind?
- Best Stocks Under $10.00
- 3 High-Potential Stocks That Could Turn Into Multi-Baggers
- The How And Why of Investing in Oil Stocks
- CEO Swap: Starbucks Surges 22% on Hiring New CEO From Chipotle
Receive News & Ratings for Ayala Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ayala Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.